Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates
Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
The main objective will be to test the safety of two intravenous infusions of Altastaph, a
human immunoglobulin product. The study will also test the ability of Altastaph to protect
against S. aureus infection.